BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 9698483)

  • 1. Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
    Odunsi KO; Peck LL; Kohorn EI; Parkash V; Cracchiolo B; Chambers JT; Taylor KJ
    Gynecol Oncol; 1998 Jul; 70(1):100-4. PubMed ID: 9698483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presentation and management of post-partum choriocarcinoma.
    Dobson LS; Gillespie AM; Coleman RE; Hancock BW
    Br J Cancer; 1999 Mar; 79(9-10):1531-3. PubMed ID: 10188902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension--a rare presentation of choriocarcinoma.
    Gangadharan VP; Chitrathara K; Sivaramakrishnan R; Satishkumar K; Nair MK
    Acta Oncol; 1993; 32(4):461-2. PubMed ID: 8396399
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
    Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report.
    Knox S; Brooks SE; Wong-You-Cheong J; Ioffe O; Meisenberg B; Goldstein DP
    Gynecol Oncol; 2002 Apr; 85(1):204-8. PubMed ID: 11925147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; CantĂș MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
    Laan R; Bakker P; Lammes FB
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
    Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
    Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
    Bilgin T; Ozan H; Ozuysal S; Ozkan L
    Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
    Kohorn EI
    Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
    Dana A; Saldanha GJ; Doshi R; Rustin GJ
    Gynecol Oncol; 1996 Apr; 61(1):147-9. PubMed ID: 8626104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
    Bircher C; Smith RP; Seckl MJ; Brown D; Short D; Rees H; McCarthy A; Nirmal DM
    BJOG; 2011 Dec; 118(13):1672-5. PubMed ID: 21790953
    [No Abstract]   [Full Text] [Related]  

  • 20. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.